Artivion to Participate in Upcoming Investor Conferences

Artivion (NYSE: AORT) has announced its participation in two upcoming investor conferences in New York.

Rhea-AI Summary

Artivion (NYSE: AORT) has announced its participation in two upcoming investor conferences in New York. The company will present at the Stifel 2024 Healthcare Conference on November 19, 2024, at 1:15p.m. ET at the Lotte New York Palace, with a live webcast available on their website. The webcast recording will be accessible for 90 days afterward.

Additionally, the management team will conduct one-on-one meetings at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 21, 2024. No webcast will be available for this event due to its format.

Argus Session date unavailable

+5.56% session move Open Argus

Details

News Market Reaction – AORT

The recorded move for AORT in the trading session of this news was +5.56%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ATLANTA, Nov. 5, 2024 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate in two upcoming investor conferences.

Artivion's management team will present at the upcoming Stifel 2024 Healthcare Conference on Tuesday, November 19, 2024, at the Lotte New York Palace. The Company's presentation is scheduled to begin at 1:15p.m. ET. A live webcast can be accessed through Artivion's website, www.artivion.com, on the Investors page. An archived copy of the webcast will be available for 90 days on the same website.

Members of the management team will also host one-on-one meetings at the upcoming Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on Thursday, November 21, 2024, in New York. Due to the format of this event no webcast will be available.

About Artivion, Inc.
Headquartered in suburban Atlanta, Georgia, Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases. Artivion's four major groups of products include: aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website, www.artivion.com.

Contacts:
Artivion	Gilmartin Group LLC
Lance A. Berry	Brian Johnston / Laine Morgan
Executive Vice President &	Phone: 332-895-3222
Chief Financial Officer	investors@artivion.com
Phone: 770-419-3355

View original content to download multimedia:https://www.prnewswire.com/news-releases/artivion-to-participate-in-upcoming-investor-conferences-302296852.html

SOURCE Artivion, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is Artivion (AORT) presenting at the Stifel 2024 Healthcare Conference?

Artivion will present at the Stifel 2024 Healthcare Conference on Tuesday, November 19, 2024, at 1:15p.m. ET at the Lotte New York Palace.

How long will Artivion's (AORT) Stifel Conference webcast be available?

The webcast recording will be available for 90 days on Artivion's website (www.artivion.com) in the Investors section.

Will there be a webcast for Artivion's (AORT) participation in the Canaccord Genuity Forum?

No, there will not be a webcast available for the Canaccord Genuity Forum due to the one-on-one meeting format of the event.

What investor events is Artivion (AORT) attending in November 2024?

Artivion is attending the Stifel 2024 Healthcare Conference on November 19 and the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 21, 2024.